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We conducted a retrospective chart review of older (n  = 48; mean 
age = 69) and younger (n  = 36; mean age = 30) patients who were 
admitted to residential/inpatient treatment for alcohol withdrawal 
and dependence. Although the two age groups did not differ in terms 
of recent drinking history, the elderly group had significantly more 
withdrawal symptoms for a longer duration than the younger group. 
The elderly group also had more symptoms of cognitive impairment, 
daytime sleepiness, weakness, and high blood pressure. Finally, no 
significant differences were found between age groups in either the 
dosage or number of days of detoxification medication, although a 
trend was found for more days of medication in the elderly. We 
conclude that alcohol withdrawal may be more severe in elderly than 
in younger persons. Accordingly, treatment may take longer and 
should target the specific profile of symptoms that characterize 
alcohol withdrawal in the elderly. 
Key Words: Withdrawal Syndrome, Alcoholism, Elderly, Drug Ther- 
apy, Residential Treatment. 
ERY LITTLE IS known about alcohol withdrawal in V elderly patients. A recent literature search revealed 
only one specific article.' Liskow et al.' reported that 
elderly alcoholics in residential treatment had more severe 
ratings of withdrawal and required higher doses of medi- 
cation for detoxification, despite consuming less alcohol 
before admission than younger alcoholics. However, the 
study sample was from a Veterans Administration hospital 
and may not represent alcoholic patients from other set- 
tings. 
Other research indicates that elderly alcoholics are more 
likely than younger alcoholics to manifest biochemical 
abnormalities, and they are likely to suffer from concom- 
itant physical and cognitive disorders that could compli- 
cate the course of withdrawal.' Indeed, a recent study 
revealed higher rates of mortality from delirium tremens 
(DTs) in elderly patients than in younger  patient^.^ An- 
other line of evidence suggests that repeated episodes of 
alcohol withdrawal result in progressively more severe 
withdrawals, a phenomenon known as kindling.4 If living 
longer is associated with more episodes of withdrawal, 
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then older alcoholics could have more severe withdrawals 
because of kindling. Kindling may also underlie with- 
drawal seizures4s5 and cognitive impairment6 in patients 
with alcohol dependence. However, we are unaware of 
studies that examined which types of withdrawal phenom- 
ena, such as seizures or cognitive impairment, are more 
likely to occur in older versus younger alcoholics. If elderly 
alcoholics do suffer more commonly from particular types 
of withdrawal phenomena, then treatment approaches 
may need to be specialized. Taken together, then, these 
studies suggest that elderly alcoholics may have severe 
withdrawal syndromes that require more medication and 
other types of specialized treatment. 
Given the apparent lack of studies comparing the course 
and treatment of alcohol withdrawal in elderly and 
younger patients, this study was conducted to test the 
following hypotheses: ( 1) elderly alcoholics experience a 
more severe course of withdrawal in terms of the quantity 
and duration of withdrawal symptoms; (2) elderly alco- 
holics are more susceptible than younger alcoholics to 
particular types of symptoms during withdrawal that are 
known to be associated with aging-in particular, elderly 
alcoholics will be more likely than younger alcoholics to 
manifest insomnia and symptoms of delirium, such as 
cognitive impairment and hallucinations; and (3) elderly 
alcoholics require higher doses of medication for detoxi- 
fication for longer durations than younger alcoholics. 
METHODS 
Design 
We conducted a retrospective chart review of patients consecutively 
discharged from 1 of 2 treatment programs during the period from 
January 1987 to April 199 1. This time period allowed us to compare 
35-50 patients/treatment program who met the inclusion and exclusion 
criteria described. Both treatment programs were located at the same 
community hospital, and one specialized in the treatment of older adults. 
Both programs exclusively admitted patients with psychoactive substance 
use disorders and they provided detoxification and rehabilitation services. 
The chart review was performed by a research nurse and a research 
assistant. The two reviewers recorded pertinent information from each 
medical chart onto a structured form that allowed for easy coding and 
computer entry. Based on a sample of 10 charts, interrater reliability for 
the two chart reviewers was 87%. 
Subjects 
We compared a younger group (ages 21-35; n = 36) and an older 
group (ages 60 and above; n = 48) of alcoholic patients. The disparity in 
age between the two groups was designed to highlight any differences 
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while minimizing the number of charts reviewed. In addition to age, 
entry criteria included both of the following: a discharge diagnosis of 
alcohol dependence and the administration of a complete course of 
sedative medication for detoxification. The requirement that a patient 
completed a course of medication for detoxification allowed us to com- 
pare this treatment modality for the two age groups. A complete course 
was defined as initiating and ending sedative medication for detoxifica- 
tion during the index hospitalization. Because patients were generally 
medicated on an as-needed basis, a complete course of medication could 
theoretically range from a single dose on 1 day to multiple doses over 14 
days. Fourteen days were chosen as the maximum period of observation 
for the study, because we reasoned that symptoms or treatments that 
lasted longer than 2 weeks were unlikely to be caused by acute alcohol 
withdrawal. Cases were excluded if they met any one of the following 
criteria: ages 36-59; sedative medication for detoxification was not 
required ( n  = 18 for the older group and 69 for the younger group); 
detoxification medication was initiated elsewhere immediately before 
admission ( n  = 16); last drink was more than 7 days before admission 
(n = 47); discharge occurred before pharmacological detoxification was 
completed (as in a discharge against medical advice) ( n  = 16); a concur- 
rent discharge diagnosis of opioid, cocaine, or other stimulant depend- 
ence ( n  = 31), because of the overlap in withdrawal symptoms; and a 
positive urine drug screen for opioids, cocaine, or amphetamines, even 
if not diagnosed with dependence ( n  = 3). 
Variables of Interest 
Six major domains of variables were studied: (1) demographics, (2) 
drinking history, (3) past history of withdrawal symptoms and past 
treatment history, (4) current medical status, ( 5 )  withdrawal symptoms 
during the reviewed treatment episode, and (6) duration and dosage of 
medications for detoxification. Age, of course, was the major independent 
variable, whereas withdrawal symptoms (quantity and duration) and 
treatment received (duration and dosage of medication) were the major 
dependent variables. Drinking history, past history, and medical status 
were studied for their possible influence on the withdrawal course and 
its treatment. Drinking history included duration of problem drinking, 
days of drinking in the month before admission, number of drinks/day, 
and recency of last drink before admission. Past history included prior 
episodes of DTs, seizures, and hallucinations. Past history also included 
the number of previous inpatient/residential treatment programs for 
alcohol dependence, which was found to correlate with seizure prevalence 
in another study.' Medical status included the results of the medical 
history, physical, and laboratory exams. Of specific interest was the 
presence of liver disease, pancreatic disease or other gastrointestinal 
disorders (gastritis, ulcers, and bleeding), and cardiac disease. Laboratory 
exam included liver function tests and a complete blood count. 
The presence of the following 17 withdrawal symptoms were recorded 
anxiety, cognitive impairment (which included disorientation or confu- 
sion), depressed mood, diaphoresis, hallucinations, headache, insomnia, 
daytime sleepiness, imtability, nausea or vomiting, psychomotor agita- 
tion, seizures, tremors, weakness, high blood pressure (systolic > 140 
mm Hg or diastolic > 90 mm Hg), pulse > 100, and temperature > 
99.6"F. (Although blood pressure, pulse, temperature, and some of the 
other withdrawal phenomena described are technically signs and not 
symptoms, for simplicity we refer to them all as symptoms for the 
purposes of this study.) Insomnia was coded as present if staff intervened 
at night with a patient due to problems with sleep. Withdrawal symptoms 
were recorded on the structured chart review form for each day that their 
presence was documented in the chart. Symptoms were recorded for the 
first 14 days of treatment or until the patient was discharged, whichever 
came first. The last day of hospitalization (up to 14 days) on which each 
symptom (except for vital signs, insomnia, and daytime sleepiness) 
occurred was recorded. Each patient's maximum last day was used to 
calculate the mean duration of the withdrawal syndrome for the group. 
The total number of documented withdrawal symptoms was also re- 
corded for each patient, with a theoretical maximum of 17 symptoms as 
listed. 
Finally, we recorded the following treatments given for withdrawal 
symptoms. The duration of pharmacotherapy in days and the total dosage 
across all days of administration were recorded for a variety of detoxifi- 
cation medications, including chlordiazepoxide, lorazepam, diazepam, 
phenobarbital, atenolol, phenytoin, and L-tryptophan. Only dosage data 
for the sedative-hypnotics (chlordiazepoxide, lorazepam, diazepam, and 
phenobarbital) are presented, because the other medications were given 
too infrequently to make meaningful comparisons between the two age 
groups. Doses of sedative-hypnotics were first converted to chlordiaze- 
poxide equivalents and then analyzed both before and after adjusting for 
weight (mg/kg). The following conversions were used: 25 mg of chlor- 
diazepoxide = 10 mg diazepam = 1 mg lorazepam = 30 mg phenobar- 
bital. 
Differences between the two age groups were analyzed by using t tests 
for continuous variables. Dichotomous variables were tested with either 
the x2 test or the Fisher's exact test if cell sues were too small. All tests 
were two-tailed. For individual withdrawal symptoms, we predicted age 
differences for 3 of 17 symptoms (cognitive impairment, hallucinations, 
and insomnia). Thus, for the remaining 14 symptoms, age comparisons 
were considered statistically significant if they were less than the Bonfer- 
roni-corrected a level of 0.0036. 
RESULTS 
Table 1 illustrates the demographic differences between 
the two age groups. As expected, older adults were more 
likely to be widowed, whereas younger adults were more 
likely to have never married. Nearly equal percentages of 
the two age groups were currently married. Older adults 
were also more likely to be retired and less likely to be 
working compared with the younger group. Finally, the 
older adults lived with significantly fewer household mem- 
bers. There were no significant differences between the 
two groups in terms of gender, race, and education. 
In terms of drinking history (Table 2), older adults had 
been problem drinkers for significantly longer than 
younger adults (19.2 vs. 10.5 years). However, no differ- 
ences were found in the number of drinks consumed/day, 
the number of drinking days in the month before admis- 
sion, or in the time of last drink before admission. Equal 
numbers of older ( n  = 5) and younger ( n  = 5) patients 
had concurrent diagnoses of sedative-hypnotic depend- 
ence. Past history did not reveal a significant difference in 
the number of previous hospitalizations for alcohol de- 
pendence, despite the longer duration of problem drinking 
Table 1. DemOgraphic Characteristics of Older and Younaer Alcoholics 
Older Youn er 











No. in householdt 







12.7 i 3.4 
15 
1.5 i 0.7 








12.2 i 2.5 NS 
70 <0.001 
2.5 i 1.2 <0.001 
* Continuous variables were analyzed by t tests and categorical variaMes by x2 
t Values are expressed as the mean i SD. + NS, not significant. 
tests. 
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Table 2. Drinking History. Past History, and Medical Status 
Variables 
Older Youn er 
fn = 481' In = %,* D valuet 
Drinking history 
Duration of problem drinking 
No. of drinks/day 
Days drank in past month 
Recency of last drink (days) 
Past history 







Other gastrointestinal disorders 
Cardiac disease 
Hypertension 
AST (5-42 IU/liter)' 
ALT (6-50 lU/liter)' 
GGTP' (1 0-70 lU/%ter)' 
Mean corpuscular volume (82- 
Hematocrit (M: 40-54%: F: 36- 
Hemoglobin (M: 13-17; F: 11- 






19.2 f 15.9 
17.8 f 11.9 
26.9 f 5.6 
0.7 f 1 .O 










72.4 f 52.9 
45.0 f 32.3 
102.2 k 106.6 
100.4 f 6.6 
40.2 f 7.1 
13.9f1.7 
6.8 f 2.2 
10.5 f 6.2 
21.5 f 14.1 
24.4 f 9.1 
0.6 f 0.8 
1.1 f 1.2 









51.3 f 44.4 
58.3 f 77.4 
93.6 f 152.5 
94.0 f 5.9 
46.4 f 3.2 
15.8 f 1.3 























* Sample size for some variables may be smaller because of missing data. 
t Continuous variables were analyzed by t tests, categorical variables by x2 
tests, unless otherwise noted. For continuous variables, mean values f SD are 
presented. 
$ NS, not significant. 
9 Fisher's Exact Two-Tailed Test was used because of small cell sizes. 
' Normal range for reference laboratory. 
' GGTP. r-glutamyltranspeptidase. 
in the older adults. Although higher percentages of older 
adults had prior episodes of seizures and DTs, these dif- 
ferences were not significant (Table 2). Older adults were 
significantly more likely to suffer from cardiac disease and 
hypertension, but no significant differences were found 
for any of the gastrointestinal disorders. Hematologically, 
older adults were more likely to exhibit macrocytosis as 
demonstrated by a mean corpuscular volume of > 100 fL. 
Older adults also had significantly lower hematocnts, he- 
moglobins, and white blood cell counts, but the mean 
values for these parameters were still within normal clin- 
ical ranges (Table 2). 
The overall course of alcohol withdrawal and the fre- 
quencies of particular types of withdrawal symptoms are 
shown in Tables 3 and 4. Overall, elderly alcoholics ex- 
perienced significantly more withdrawal symptoms (6.8 
vs. 5.6) for a longer time (9.0 days vs. 6.5 days) than 
younger alcoholics (Table 3). None of the patients had 
seizures during withdrawal, but each of the other with- 
drawal symptoms were documented at various frequencies 
(Table 4). The older group (50%) was much more likely 
than the younger group (8%) to suffer from cognitive 
impairment (x2 = 16.4, df= 1, p < 0.001), weakness (48% 
vs. 8%; x2 = 15.1, df= 1, p < 0.001), and high blood 
Table 3. Overall Course and Treatment of Alcohol Withdrawal by Age Group 
Variables (n = 48)' (n = 36)' p valuet 
Older Younger 
Overall course 
Total no. of withdrawal symptoms 6.8 f 2.0 5.6 f 2.2 0.016 
Last day of symptoms (hospital 9.0 f 4.3 6.5 f 4.2 0.01 1 
day no.) 
Withdrawal treatment 
Unadjusted chlordiazepoxide dose 159.7 & 105.7 151.5 f 119.4 NS$ 
Total chlordiazepoxide dose (mg/ 2.3 f 1.6 2.1 f 1.6 NS 
Duration of pharmacotherapy 3.5 f 3.5 2.3 f 2.4 NS 
kg) 
(davs)§ 
~~~ ~~ ~ 
* Sample size for some variables may be smaller because of missing data. 
t Mean values f SD are presented. Differences between means were analyzed 
$ NS,  not significant. 
5 Represents the number of days (not the last hospital day) on which medication 
by t tests. 
was given. 
Table 4. Frequency of Alcohol Withdrawal Symptoms by Age Group 
Older Youn er 
Variables (n = 48)' (n = f6)' p valuet 
Frequency (%) of specific symptoms 
Anxiety 77% 89% NSS 
Cognitive impairment 50% 8% <0.001 
Depressed mood 65% 50% NS 
Diaphoresis 35% 33% NS 





Nausea or vomiting 
Psychomotor agitation 
Shakes or tremors 
Seizures 
Weakness 































High pulse (>lo0 beatslmin) 65% 67% NS 
High temperature (>99.6"F) 8% 7% NS 
Other parameters 
Highest systolic pressure (mm Hg) 167.5 f 22.3 144.7 f 14.0 <0.001 
Highest diastolic pressure (mm Hg) 92.4 f 11.7 94.8 f 13.2 NS 
Highest temperature (OF) 98.3 f 0.9 98.7 f 0.6 NS 
Highest pulse (beats/min) 109.6 f 17.5 108.8 f 16.4 NS 
* Sample size for some variables may be smaller because of missing data. 
t Continuous variables were analyzed by t tests, categorical variables by x2 
tests, unless otherwise noted. For continuous variables, mean values f SD are 
presented. 
$ NS, not significant. 
5 Either systolic pressure > 140 or diastolic pressure > 90 mm Hg. 
pressure (88% vs. 69%; x2 = 4.2, df = 1, p = 0.042). 
Although high blood pressure did not meet significance 
after applying the Bonferroni-corrected level of p = 
0.0036, the difference between highest systolic pressures 
did (Table 4). By contrast, the younger group (33%) was 
more likely than the older group (4%) to suffer from 
headaches (x2 = 12.6, df= 1, p < 0.001). A nonsignificant 
trend existed for more insomnia in the elderly. Elderly 
alcoholics were more than twice as likely to complain of 
daytime sleepiness, which was nominally significant ( x2 = 
5.0, df= 1, p = 0.026). Daytime sleepiness could have 
reflected the effect of either insomnia or sedation from 
detoxification medication. To help differentiate these fac- 
tors, we looked for a correlation between dose of chlordi- 
ALCOHOL WITHDRAWAL IN ELDERLY VS. YOUNGER PATIENTS 199 
azepoxide equivalents and duration of daytime sleepiness 
in the elderly. We did not find a significant correlation (rs 
= -0.18, p = 0.24), suggesting that daytime sleepiness was 
not a side effect of medication. Likewise, we did not find 
significant correlations between dosage of sedative medi- 
cation and either cognitive impairment (rs = 0.08, p = 
0.60) or weakness (rs = -0.02, p = 0.88) in the elderly, 
suggesting that these symptoms were not measuring side 
effects of medication either. 
Both before and after adjusting for weight, elderly al- 
coholics did not require higher doses of chlordiazepoxide 
equivalents than younger alcoholics (Table 3). Likewise, 
the elderly did not require significantly more days of 
detoxification medication (Table 3). Nevertheless, a non- 
significant trend existed for more days of detoxification 
medication in the elderly (3.5 vs. 2.3 days). It should be 
noted that the duration of pharmacotherapy refers to the 
number of days on which medication was given. We did 
not record the value of the last hospital day on which 
medication was given. 
DISCUSSION 
We found that among alcoholics who underwent phar- 
macological detoxification in an inpatient/residential set- 
ting, the elderly group manifested a larger number of 
withdrawal symptoms for a longer duration than the 
younger group. Thus, we found support for our first 
hypothesis that elderly alcoholics undergo a more severe 
course of withdrawal than younger alcoholics. 
The elderly were also more likely to experience symp- 
toms of cognitive impairment, daytime sleepiness, weak- 
ness, and high blood pressure; whereas younger alcoholics 
were more likely to suffer from headaches during with- 
drawal. Contrary to our prediction, we did not find that 
older alcoholics were more likely than younger alcoholics 
to suffer hallucinations during withdrawal. The greater 
frequencies of cognitive impairment, daytime sleepiness, 
weakness, and high blood pressure in the elderly may have 
reflected underlying medical conditions rather than with- 
drawal symptoms per se. For example, the greater values 
for high blood pressure during withdrawal in the elderly 
group may have reflected the higher prevalence of under- 
lying hypertensive disease in our elderly sample (Table 2). 
Likewise, cognitive impairment, daytime sleepiness, and 
weakness in the elderly may have been caused by under- 
lying medical conditions such as cardiac disease, hyperten- 
sion, and anemia rather than by withdrawal per se. More- 
over, elderly individuals in general and elderly alcoholics 
in particular are more susceptible than younger individ- 
uals to develop sleep disorders such as sleep apnea, which 
can result in daytime sleepiness and cognitive impair- 
rne~~t.~.' 
To examine some of these possibilities, we analyzed 
whether elderly alcoholics with medical conditions were 
more likely to suffer from daytime sleepiness, cognitive 
impairment, or weakness than elderly alcoholics without 
each of the medical conditions listed in Table 2. We 
conducted 36 comparisons (3 symptoms X 12 medical 
conditions and lab tests). Only two comparisons were 
significant (Table 5). Elderly patients with cardiac disease 
were more likely to suffer cognitive impairment (63%) 
during withdrawal than were elderly patients without car- 
diac disease (33%) ( x 2  = 4.1, df = 1, p = 0.042). Also, 
elderly patients with hypertension were more likely to 
have daytime sleepiness (73%) than elderly patients with- 
out hypertension (33%) (x2 = 5.3, df = 1, p = 0.021). 
Although no other comparisons were significant, we were 
unable to rule out the effects of other conditions that 
accompany aging such as reduced cardiac output, changes 
in the sleep-wake cycle, and sleep disorders. 
We further reasoned that if symptoms were due to 
withdrawal that we should be able to demonstrate revers- 
ibility, whereas if they were due to underlying medical 
conditions then they should persist. For two symptoms, 
cognitive impairment and weakness, data were collected 
regarding the last hospital day that the symptom occurred. 
The mean last hospital day for cognitive impairment in 
the elderly (day 3.7 f 4.8) was later than in the younger 
group (day 0.3 f 1.2) (Wilcoxon 2-sample test: Z = -4.1, 
p < 0.001). Likewise, the mean last hospital day for 
weakness in the elderly (day 1.8 f 3.0) was later than in 
the younger group (day 0.2 k 0.9) (Wilcoxon 2-sample 
test: Z = -3.7, p < 0.001). Most importantly, both cog- 
nitive impairment and weakness in the elderly ended 
sooner than withdrawal symptoms taken together (day 9.0 
k 4.3) (Table 3). These data, then, demonstrate that 
cognitive impairment and weakness lasted longer, but 
were still reversible symptoms in the elderly, which is 
consistent with acute withdrawal rather than with under- 
lying chronic disease. 
Finally, we considered the possibility that cognitive 
impairment, daytime sleepiness, and weakness were side 
effects of sedative-hypnotic medication. 'O," However, the 
lack of significant correlations between the dosage of 
medication and the durations of each of the three symp- 
toms suggests that these symptoms were not simply side 
effects of detoxification medication. Therefore, we con- 
clude, consistent with our second hypothesis, that elderly 
alcoholics are more susceptible than younger alcoholics to 
particular types of symptoms during withdrawal, although 
we falsely predicted hallucinations and failed to predict 
high blood pressure. We also conclude that other medical 
conditions may influence the type of withdrawal symp- 
toms found in the elderly. 
We did not find strong support for our third hypothesis. 
Although the elderly group was treated with detoxification 
medication for slightly more days than the younger group, 
the difference was not significant. Also contrary to our 
prediction, equivalent doses of medication were used in 
the older and younger groups. The lack of difference in 
medication dosage despite more withdrawal symptoms in 
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Table 5. Withdrawal Symptoms as a Function of Cardiac Disease in the Elderly (n = 48)’ 
Symptom Yes No p valuet Yes No p valuet 
Cardiac disease Hypertension 
Cognitive impairment 63.0% 33.3% 0.042 66.7% 44.4% NSS 
Daytime sleepiness 50.0% 33.3 NS 72.7% 33.3% 0.021 
Weakness 55.6% 38.1% NS 41.7% 50.0% NS 
* Sample size for some variables may be smaller because of missing data. 
t x2 two-tailed tests, df = 1. + NS. not significant. 
the elderly group is at odds with the finding of Liskow et 
al.’ We speculate that the particular types of withdrawal 
symptoms which the elderly manifested (i.e., cognitive 
impairment, daytime sleepiness, and weakness) contrain- 
dicated higher doses of a sedative-hypnotic. Furthermore, 
elderly individuals are generally more susceptible than 
younger individuals to the effects of benzodiazepines, 
because of altered pharmacokinetics and, perhaps, greater 
neuroreceptor response in the elderly. ’ We believe, 
therefore, that the prescribing physicians curtailed dosages 
appropriately. We further contend that similar doses for 
slightly longer durations in the elderly actually signified 
greater medication needs, because of the known altered 
pharmacokinetic and pharmacodynamic responses to sed- 
ative-hypnotics in the elderly. I 
Some research suggests that the severity of alcohol with- 
drawal increases with increasing episodes of withdrawal, 
because of a kindling phen~menon.~ Thus, elderly alco- 
holics might be expected to have a more severe withdrawal 
course because of a longer history of previous withdrawal 
episodes. We were unable to quantify precisely the number 
of previous withdrawal episodes, because of the retrospec- 
tive nature of the study. As an indirect measure, the 
number of prior hospitalizations for alcohol treatment was 
used, which has been found to correlate with seizure 
prevalence in  alcoholic^.^ The number of prior hospitali- 
zations did not differ significantly between the two age 
groups even though the elderly alcoholics had been prob- 
lem drinkers for more than 8 years longer (Table 2). We 
can only speculate that the younger alcoholics had as 
many admissions as the elderly because their earlier age 
of onset was associated with severe social consequences 
that precipitated hospital admissions. l 2  In any case, we 
did not find significant correlations between the number 
of prior hospitalizations and the severity of withdrawal 
symptoms (total number or duration). 
Liskow et al. ‘ reported that elderly (predominantly 
male) alcoholics at a Veterans Administration hospital 
had more severe ratings of withdrawal and required higher 
doses of medication for detoxification. Our study extends 
the finding of greater withdrawal severity in elderly alco- 
holics to women and to patients found in a community 
hospital setting. However, we did not find a difference in 
dosage between our elderly and younger groups. 
The retrospective design of our study limits the conclu- 
sions that can be drawn from the data. Withdrawal scales 
were not used by the two treatment programs to measure 
the type and seventy of symptoms. Thus, the type, quan- 
tity, and duration of withdrawal symptoms that we meas- 
ured were dependent on the quality of documentation in 
the medical record. Because time-conscious clinicians are 
most likely to document symptoms only when the symp- 
tom requires some clinical action, our data probably rep 
resent underestimates of the actual number and durations 
of withdrawal symptoms. In other words, only the most 
severe symptoms were likely to be documented. This 
limitation should apply equally to the two age groups. 
Consequently, we believe that the absolute values of the 
withdrawal measures in Tables 3 and 4 are not as mean- 
ingful as the differences between groups. 
Another limitation of the study concerns the possible 
differences both in charting and in the tendency to medi- 
cate patients between the two treatment units. It is possible 
that staff on the older adult unit more compulsively re- 
corded withdrawal phenomena than the staff on the other 
unit did. This would give the appearance of more with- 
drawal symptoms in the older adult group. It is also 
possible that the physicians and nurses on the older adult 
unit were more or less likely to use medications than the 
other treatment staff did because of differences in treat- 
ment orientation or philosophy. Indeed, orders for seda- 
tive medication were typically written on an as-needed 
basis. Thus, nursing staff used their discretion as to how 
much medication was given. On the other hand, the two 
units shared the same medical director, who was also the 
attending physician for most cases studied, and the same 
clinical director. Although each unit may have developed 
its own specific programming and “treatment culture,” 
there was enough overlap in clinical and administrative 
staff to permit comparisons for the purpose of this study. 
Nevertheless, caution is warranted in the interpretation of 
our results. A stronger study design would standardize the 
charting and treatment protocols across units. 
In conclusion, our study provides further support that 
alcohol withdrawal may be more severe in the elderly. 
Treatment programs and third-party payers should rec- 
ognize that both the course of alcohol withdrawal and its 
treatment are likely to be longer in the older adult than in 
the younger adult. To determine more precisely how much 
longer symptoms occur, future research should use a 
prospective design and structured rating scales for meas- 
uring withdrawal symptoms. Finally, some withdrawal 
symptoms occur more commonly in the elderly than in 
younger adults, such as cognitive impairment, daytime 
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sleepiness, weakness, and high blood pressure. Such symp- 
toms may in part reflect underlying medical conditions 
and may require specialized interventions by medical and 
nursing staff. Whether benzodiazepines are the optimal 
pharmacotherapy for alcohol withdrawal when character- 
ized by such symptoms is another subject for further 
research. 
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